sulfasalazine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, H | 1 |
| Hu, K | 1 |
| Zhang, T | 1 |
| Ren, H | 1 |
| Wei, CW | 1 |
| Yu, YL | 1 |
| Lu, JY | 1 |
| Hung, YT | 1 |
| Liu, HC | 1 |
| Yiang, GT | 1 |
2 other studies available for sulfasalazine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Identification of Target Genes Related to Sulfasalazine in Triple-Negative Breast Cancer Through Network Pharmacology.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Computational Biology; Female; Gene Regulatory Networks; Hu | 2020 |
Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells.
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, T | 2019 |